Fever Screening System Market Size, Growth Trends & Insights Analysis Report by Type (Accuracy ≤0.5℃, Accuracy ≤0.4℃, Accuracy ≤0.3℃, Others), by Application (Hospitals and Clinics, Airport, Station, Subway, Government Agencies, Large Factory, School, Business Center, Others), by Region, and Competitive Landscape Forecasts, 2024-2033

The global Fever Screening System market is projected to exhibit substantial growth in the coming years, with a CAGR of 8.16% from 2024 to 2033, reaching a total market size of $512.24 million USD in 2024. A Fever Screening System is a highly accurate, automated temperature measurement system designed for mass screening of multiple human subjects in real-time. These systems are crucial for detecting and tracking individuals with elevated skin temperatures in high-traffic areas such as airports, hospitals, schools, government facilities, and public events. The technology relies on advanced thermal imaging and infrared detection to identify potential fever cases quickly and efficiently, thereby aiding in the early detection and containment of infectious diseases

Global Fever Screening System Market Size and Growth Rate (2024-2033)

The growth of the Fever Screening System market is driven by several key factors. The most significant driver is the ongoing COVID-19 pandemic, which has heightened the demand for non-contact temperature screening solutions. With over 60 million confirmed cases globally, the need for rapid and accurate fever detection has become critical. Governments and organizations worldwide have implemented strict measures to curb the spread of the virus, making fever screening systems an essential tool for initial screening in public places.

Another driving factor is the wide range of applications for these systems. Originally used primarily at customs and airports, fever screening systems are now being deployed in hospitals, workplaces, schools, residential complexes, and other gathering places. The ability to conduct fast, non-contact measurements and monitor large fields of view makes these systems ideal for high-traffic scenarios. For example, China’s Ministry of Industry and Information Technology (MIIT) reported a demand for approximately 60,000 infrared temperature detectors nationwide, highlighting the significant market potential.

Policy support from regulatory bodies such as the FDA has also played a crucial role in market growth. The FDA temporarily allowed the marketing of infrared thermal camera systems for temperature checks in places like warehouses and factories during the COVID-19 public health emergency. Similar measures by other regulatory agencies have further boosted the adoption of these systems.

However, the market also faces several limiting factors. One major challenge is the highly competitive nature of the market. The surge in demand has attracted numerous new entrants, leading to increased competition for raw materials and market share. This competition may result in lower profitability for existing firms. Additionally, the rapid expansion of production capacity by manufacturers could lead to oversupply and market saturation.

Another limitation is the functional constraints of fever screening systems. These systems are designed for relative temperature difference detection and are not absolute temperature measurement tools. Achieving accurate measurements requires strict environmental control, which can compromise the ease of use and speed of screening. Furthermore, the effectiveness of symptom screening, especially temperature screening, in preventing virus transmission is debated, as many carriers may be asymptomatic.

The Fever Screening System market is witnessing significant technological innovation and corporate activity. Companies are continuously improving the accuracy and reliability of their systems, with a focus on developing solutions that offer higher precision and faster screening capabilities. For example, some systems now integrate AI algorithms to enhance detection accuracy and reduce false alarms.

Corporate mergers and acquisitions are also shaping the market landscape. Major players such as FLIR Systems and Honeywell have engaged in strategic acquisitions to expand their product portfolios and enhance their market positions. FLIR Systems acquired Altavian, Inc., a manufacturer of small unmanned aerial systems, to integrate advanced thermal technology into its solutions. Honeywell’s acquisition of Rocky Research, a leader in thermal and power management solutions, aims to expand its capabilities in the fast-growing power and thermal management market.

In addition to these strategic moves, companies are also focusing on expanding their sales channels and establishing strong partnerships. Distributors and resellers play a crucial role in reaching end-users, and companies are leveraging these relationships to penetrate new markets and increase their market share. The development of new sales channels and the establishment of strong customer relationships are essential for companies to remain competitive in this dynamic market.

In conclusion, the Fever Screening System market is poised for significant growth, driven by the ongoing pandemic and the increasing demand for efficient fever detection solutions. While the market faces challenges such as intense competition and functional limitations, technological innovation and strategic corporate activities are helping companies navigate these hurdles and capitalize on emerging opportunities.

In 2024, the global Fever Screening System market is expected to generate a total revenue of $512.24 million USD. The market segmentation by type shows the following revenue and market share distribution:

1. Accuracy ≤0.5℃: This segment is projected to generate a revenue of $157.54 million USD, accounting for 30.76% of the total market share.

2. Accuracy ≤0.4℃: The revenue for this segment is estimated at $45.86 million USD, with a market share of 8.95%.

3. Accuracy ≤0.3℃: This segment is expected to dominate the market with a revenue of $264.39 million USD, holding a significant market share of 51.61%.

4. Others: The remaining segment, categorized as “Others,” is projected to generate $44.46 million USD in revenue, representing 8.68% of the total market share.

These figures highlight the growing demand for high-accuracy fever screening systems, particularly those with an accuracy of ≤0.3℃, which are preferred for critical applications such as healthcare facilities, transportation hubs, and public venues.

Type

Market Size in 2024 (M USD)

Market Share in 2024 (%)

Accuracy ≤0.5℃

157.54

30.76%

Accuracy ≤0.4℃

45.86

8.95%

Accuracy ≤0.3℃

264.39

51.61%

Others

44.46

8.68%

In 2024, the global Fever Screening System market is expected to generate a total revenue of $512.24 million USD. The market segmentation by application shows the following revenue and market share distribution:

1. Hospitals and Clinics: This segment is projected to generate a revenue of $80.25 million USD, accounting for 15.67% of the total market share.

2. Airport: The revenue for this segment is estimated at $38.71 million USD, with a market share of 7.56%.

3. Station: This segment is expected to generate a revenue of $100.90 million USD, holding a market share of 19.70%.

4. Subway: The revenue for this segment is projected to be $51.61 million USD, representing 10.07% of the total market share.

5. Government Agencies: This segment is expected to generate a revenue of $61.08 million USD, with a market share of 11.93%.

6. Large Factory: The revenue for this segment is estimated at $63.77 million USD, accounting for 12.45% of the total market share.

7. School: This segment is projected to generate a revenue of $39.84 million USD, holding a market share of 7.78%.

8. Business Center: The revenue for this segment is estimated at $49.47 million USD, representing 9.67% of the total market share.

9. Others: This segment is expected to generate a revenue of $30.60 million USD, with a market share of 5.97%.

These figures highlight the diverse applications of fever screening systems across various sectors, with stations and hospitals and clinics being significant contributors to the overall market revenue.

Application

Market Size in 2024 (M USD)

Market Share in 2024 (%)

Hospitals and Clinics

80.25

15.67%

Airport

38.71

7.56%

Station

100.90

19.70%

Subway

51.61

10.07%

Government Agencies

57.08

11.14%

Large Factory

63.77

12.45%

School

39.84

7.78%

Business Center

49.47

9.66%

Others

30.60

5.97%

In 2024, the global Fever Screening System market is projected to generate a total revenue of $512.24 million USD. The market segmentation by region shows the following revenue and market share distribution:

1. North America: This region is expected to generate a revenue of $153.88 million USD, accounting for 30.04% of the total market share.

2. Europe: The revenue for this region is estimated at $135.16 million USD, with a market share of 26.39%.

3. Asia Pacific: This region is projected to generate a revenue of $179.18 million USD, holding a significant market share of 34.98%.

4. Latin America: The revenue for this region is estimated at $23.94 million USD, representing 4.67% of the total market share.

5. Middle East and Africa: This region is expected to generate a revenue of $20.07 million USD, with a market share of 3.92%.

These figures highlight the growing demand for fever screening systems across different regions, with Asia Pacific expected to dominate the market due to increasing healthcare infrastructure investments and rising demand in countries like China and India.

Global Fever Screening System Market Share by Region in 2024

FLIR Systems is a leading global manufacturer of thermal imaging and sensing solutions. Established in 1978, FLIR is headquartered in Oregon, USA. The company specializes in designing, developing, and manufacturing a wide range of technologies that enhance perception and awareness. FLIR’s product portfolio includes thermal imaging cameras, visible-light imaging systems, video analytics, measurement and diagnostic tools, and advanced threat detection systems. These solutions are widely used in government and defense, industrial, and commercial markets.

FLIR offers a variety of fever screening systems designed for high-accuracy temperature measurement. One notable product is the FLIR A700-EST™ IS, a non-contact screening tool that detects elevated skin temperatures. This system combines a thermal camera with a user-friendly interface to quickly identify individuals with potential fever symptoms. Another advanced product is the FLIR Elara™ FR-345-EST, a fixed-mount thermal security camera that measures skin temperature accurately without contact.

FLIR Systems is projected to generate 155.99 M USD revenue from its fever screening systems. FLIR’s market leadership and extensive product offerings suggest a substantial share of the global fever screening system market.

Dahua Technology, headquartered in Hangzhou, China, is a leading global provider of video surveillance solutions. Established in 2001, Dahua has grown to become one of the largest players in the security and surveillance industry. The company specializes in developing and manufacturing a wide range of products, including cameras, digital video recorders (DVRs), network video recorders (NVRs), and intelligent video analytics solutions. Dahua’s business strategy focuses on leveraging advanced technologies such as AI, IoT, and cloud computing to enhance its product offerings and provide comprehensive security solutions for various applications.

Dahua Technology offers a variety of fever screening systems designed to meet the needs of different environments and applications. One of their notable products is the Thermal Temperature Monitoring Solution, which includes a thermal hybrid network camera, a blackbody reference, and a 16-channel NVR. This solution is designed for high-accuracy temperature screening in crowded public places such as airports, hospitals, and transportation hubs. The system can detect elevated skin temperatures with an accuracy of ±0.3°C when used with a blackbody reference, making it suitable for rapid and efficient fever screening.

Another key product is the WizMind series, which integrates AI capabilities for advanced analytics and contact-free human temperature monitoring. This series is designed to meet the requirements of high-end vertical markets, such as finance, retail, and transportation, where accurate and efficient fever screening is crucial.

Dahua Technology is expected to continue its strong performance in the fever screening system market. Although specific revenue figures for fever screening systems alone are not disclosed, Dahua’s overall revenue growth trend provides a positive outlook. Dahua reported a total revenue of approximately 37.05 Million USD, representing a year-over-year growth of 12.43%. This growth is driven by the company’s focus on innovation and expanding its product portfolio to meet the increasing demand for advanced security and health screening solutions.

Fluke Corporation, a wholly-owned subsidiary of Fortive Corporation, is the world leader in the manufacture, distribution, and service of electronic test tools and software. Founded in 1948, Fluke is headquartered in Everett, Washington, USA. The company specializes in producing a wide range of electronic instruments, including test and measurement tools, calibration equipment, and diagnostic devices. Fluke’s mission is to deliver essential technology that makes the world stronger, safer, and smarter.

Fluke offers a diverse portfolio of products designed to meet the needs of various industries, including:

Electronic Test Tools: These tools are used for electrical testing, safety, and calibration, ensuring that electrical systems operate safely and efficiently.

Diagnostic Equipment: Fluke’s diagnostic tools are used in medical and industrial settings to identify and resolve issues quickly.

Industrial Software: The company also provides software solutions for industrial applications, enhancing process control and quality assurance.

Thermal Imaging Solutions: Fluke’s thermal imaging cameras are used for non-contact temperature measurement and condition monitoring, particularly useful in fever screening systems.

In the latest available financial year, Fluke Corporation reported an annual revenue of approximately 35.74 Million USD. This revenue is generated through a combination of sales from its extensive product portfolio, including test and measurement equipment, diagnostic tools, and software solutions.

Partagez votre amour
fr_FRFrançais